AVS
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
451 D St Ste 802, Boston, Massachusetts,...Phone Number
(754) 755-1530Website
www.avspulse.comRevenue
$25.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About AVS
AVS is a medical device company focused on safely and effectively treating calcified arterial disease. Founded in 2017 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer, AVS is redefining interventional therapy for severely calcified lesions. And with the company's Pulse IVL system, were revolutionizing intravascular lithotripsy and transforming how physicians treat calcified arterial disease.Explore more
AVS Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AVS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if AVS is spiking on competitors!
Check if AVS has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if AVS had a recent Job posting/layoffs
Earning: See what the market has to say on AVS recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at AVS
Product Launch: Get notified when AVS launches new products
AVS, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once AVS has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AVS
Compare insights from companies similar to AVS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AVS is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AVS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AVS.
AVS financials insights
Gather financial insights about AVS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series B
$20M
Series B
$8.8M
2025
Series B
$36M
AVS Tech Stack
A closer look at the technologies used by AVS
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Person-Based
Person-Based
Funding
Funding
New Hire
Executive Move
AVS News & Media
AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study
BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it has enrolled the first patient(s) in its U.S. pivotal trial for Pulsatile Intravascular Lithotripsy (PIVL) therapy. The POWER PAD II clinical study will evaluate the safety and efficacy of AVS’s Pulse IVL™ System for the treatment of patients with moderate to severely calcified peripheral arterial disease. NicAVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid Indications
BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy platform, today announced it has entered into a strategic agreement with the Jacobs Institute, a nonprofit medical device innovation center in Buffalo, N.Y., led by Adnan Siddiqui, M.D. The partnership will execute clinical studies evaluating the Pulse IVL™ System in both Coronary and Carotid vAVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study
BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin its pivotal trial for pulsatile intravascular lithotripsy (PIVL) therapy. The POWER-PAD-II clinical study will evaluate the safety and efficacy of AVS’s Pulse IVL™ System for the treatment of patien
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AVS
Sign Up For FreeTo access detailed company insights
AVS is a medical device company focused on safely and effectively treating calcified arterial disease. Founded in 2017 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer, AVS is redefining interventional therapy for severely calcified lesions.... Read More
